Company intelligence / Profile preview
Polpharma
Starogard Gdański, Polandpolpharma.pl ↗
- Ownership
- Private
- Employees
- ~5600
- Development stage
- Commercial
01
Overview
Polpharma leads the Polish pharmaceutical market with over EUR €1.1 billion in annual revenue and produces more than 400 million medicine packages per year. It has extensive experience in generics and APIs with recent expansion into high-potency APIs for oncology and rare diseases. Its biologic division focuses on biosimilars but no specific clinical results are publicly highlighted.
- Therapeutic areas
- OncologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecules (generics and APIs)Biologics/biosimilarsHighly potent active pharmaceutical ingredients (HP API)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Outlicensing/distribution partners active in over forty countries globally
Beyond the preview
Go deeper on Polpharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polpharma.